Literature DB >> 12871560

Multi-therapeutic approach to manage delivery in an alloimmunized patient with type 3 von Willebrand disease.

C Boyer-Neumann, M Dreyfus, M Wolf, A Veyradier, D Meyer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12871560     DOI： 10.1046/j.1538-7836.2003.00009.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  4 in total

1.  Factor VIII-mediated global hemostasis in the absence of von Willebrand factor.

Authors:  Masahiro Takeyama; Shogo Kasuda; Yoshihiko Sakurai; Midori Shima; Tomohiro Takeda; Shoko Omura; Hiroyuki Naka; Akira Yoshioka
Journal:  Int J Hematol       Date:  2007-06       Impact factor: 2.490

2.  Successful Desensitization of a Patient with Possible IgE-Mediated Anaphylactic Reaction to FVIII/VWF Concentrate.

Authors:  Burcin Beken; Velat Celik; Pinar Gokmirza Ozdemir; Tuba Eren; Mehtap Yazicioglu
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2019-06-17       Impact factor: 1.349

3.  Efficacy of Octocog Alfa (Advate) in a Child with Type 3 von Willebrand Disease and Alloantibodies.

Authors:  Gianluca Sottilotta; Francesca Luise; Elisabetta Massara; Vincenzo Oriana; Angela Piromalli
Journal:  J Clin Med       Date:  2017-09-18       Impact factor: 4.241

Review 4.  How I manage severe von Willebrand disease.

Authors:  Frank W G Leebeek; Ferdows Atiq
Journal:  Br J Haematol       Date:  2019-09-09       Impact factor: 6.998
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.